Clinical Trial: AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title:
Brief Summary: This study will evaluate the safety and efficacy of AGN-229666 for the prevention of allergen-mediated conjunctivitis.
Detailed Summary:
Sponsor: Allergan
Current Primary Outcome: Ocular Itching Score [ Time Frame: Days 1 and 15 ]
Original Primary Outcome: Ocular Itching Score Using a 6-Point Scale [ Time Frame: Day 15 ]
Current Secondary Outcome: Conjunctival Hyperemia Score [ Time Frame: Days 1 and 15 ]
Original Secondary Outcome: Conjunctival Hyperemia Score Using a 9-Point Scale [ Time Frame: Day 15 ]
Information By: Allergan
Dates:
Date Received: June 9, 2014
Date Started: June 2014
Date Completion:
Last Updated: February 8, 2016
Last Verified: February 2016